These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Closure of postoperative anastomotic fistulas with a somatostatin analogue]. Niv Y, Hadari A, Asaf V, Oren M. Harefuah; 1991 Jun 02; 120(11):647-8. PubMed ID: 1937211 [Abstract] [Full Text] [Related]
3. [Somatostatin in the medical treatment of fistula of the pancreas and the small intestine]. Hild P, Stoyanov M, Dobroschke J, Aigner K. Sem Hop; 1982 Oct 21; 58(38):2195-8. PubMed ID: 6129704 [Abstract] [Full Text] [Related]
5. [Somatostatin in pancreas and small intestine fistulas]. Jost JO, Clemens M, Rühland D, Bünte H. Zentralbl Chir; 1984 Oct 21; 109(8):527-31. PubMed ID: 6203259 [Abstract] [Full Text] [Related]
6. Treatment of external pancreatic fistulas with somatostatin. Second place winner: Conrad Jobst award. Lansden FT, Adams DB, Anderson MC. Am Surg; 1989 Dec 21; 55(12):695-8. PubMed ID: 2574557 [Abstract] [Full Text] [Related]
7. Evaluation of the effectiveness of octreotide in the conservative treatment of postoperative enterocutaneous fistulas. Alivizatos V, Felekis D, Zorbalas A. Hepatogastroenterology; 2002 Dec 21; 49(46):1010-2. PubMed ID: 12143189 [Abstract] [Full Text] [Related]
8. Short-term administration of SMS 201-995 in the management of an external pancreatic fistula. Kwan D, Aufses AH. Am J Gastroenterol; 1989 Mar 21; 84(3):326-8. PubMed ID: 2919593 [Abstract] [Full Text] [Related]
9. Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure? Martineau P, Shwed JA, Denis R. Am J Surg; 1996 Oct 21; 172(4):386-95. PubMed ID: 8873537 [Abstract] [Full Text] [Related]
10. [Gastrointestinal fistulas. Treatment with a somatostatin analogue (SMS 201-995)]. Gerardo Pérez D, Bernardo Acosta M. G E N; 1994 Oct 21; 48(4):209-18. PubMed ID: 7557275 [Abstract] [Full Text] [Related]
11. Fluctuations in the secretion of pancreatic enzymes between consecutive doses of octreotide: implications for the management of fistulae. Jenkins SA, Nott DM, Baxter JN. Eur J Gastroenterol Hepatol; 1995 Mar 21; 7(3):255-8. PubMed ID: 7743308 [Abstract] [Full Text] [Related]
12. Treatment of external biliary, pancreatic and intestinal fistulas with a somatostatin analog. Kocak S, Bumin C, Karayalcin K, Alacayir I, Aribal D. Dig Dis; 1994 Mar 21; 12(1):62-8. PubMed ID: 8200125 [Abstract] [Full Text] [Related]
13. [Conservative treatment of fistulas of the pancreas and the small intestine with somatostatin (author's transl)]. Hild P, Stoyanov M, Dobroschke J, Aigner K. Ann Chir; 1982 Mar 21; 36(3):193-6. PubMed ID: 6124203 [No Abstract] [Full Text] [Related]
14. [Somatostatin analogue in the treatment of neuroendocrine gut tumors]. Ben Yosef R, Glaser B, Catane R. Harefuah; 1990 Jul 21; 119(1-2):15-8. PubMed ID: 2172125 [Abstract] [Full Text] [Related]
15. [The somatostatin analog SMA (201-995) as adjuvant treatment in patients with external fistulae of the digestive system]. Castañón González JA, Miranda Ruíz R, Arías E, Fuentes Pintado E, Zárate Treviño A. Gac Med Mex; 1992 Jul 21; 128(3):285-8. PubMed ID: 1302733 [Abstract] [Full Text] [Related]
16. [Management of postoperative pancreatic fistula resistant to octreotide therapy]. Dobosz M, Dymecki D, Babicki A, Hać S, Gruca Z, Wajda Z. Wiad Lek; 2001 Jul 21; 54(7-8):380-5. PubMed ID: 11641892 [Abstract] [Full Text] [Related]